NCT03254589View on ClinicalTrials.gov

Methotrexate, Blood Pressure and Arterial Function in Rheumatoid Arthritis

PHASE4CompletedINTERVENTIONAL
Enrollment

124

Participants

Timeline

Start Date

October 1, 2017

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions
Rheumatoid ArthritisStiffness, AorticEndothelial DysfunctionCardiovascular Risk Factor
Interventions
DRUG

Methotrexate

See arm descriptions

DRUG

Sulfasalazine

See arm description

DRUG

Other DMARDs

See arm

Trial Locations (1)

5042

Southern Adelaide Local Health Network, Bedford Park

All Listed Sponsors
collaborator

University of South Australia

OTHER

collaborator

medac GmbH

INDUSTRY

lead

Flinders University

OTHER

NCT03254589 - Methotrexate, Blood Pressure and Arterial Function in Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter